다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Biological psychiatry, v.49 no.3, 2001년, pp.258 - 267
Rezvani, Amir H (Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina USA) , Levin, Edward D (Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina USA)
AI-Helper
AbstractNicotine and other nicotinic agonists have been found to improve performance on attention and memory tasks. Clinical studies using nicotine skin patches have demonstrated the efficacy of nicotine in treating cognitive impairments associated with Alzheimer’s disease, schizophrenia, and ...
Am J Psychiatry Adler 150 1856 1993 10.1176/ajp.150.12.1856 Normalization of auditory physiology by cigarette smoking in schizophrenic patients
Pharmacol Biochem Behav Arendash 52 517 1995 10.1016/0091-3057(95)00119-H Nicotine enhances the learning and memory of aged rats
Brain Res Arendash 674 252 1995 10.1016/0006-8993(94)01449-R Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21
Arneric 3 2000 Nicotine in Psychiatry Neurobiology and clinical pathophysiology of neuronal nicotinic acetylcholine receptors
Behav Neural Biol Brioni 59 57 1993 10.1016/0163-1047(93)91159-K Nicotinic receptor agonists facilitate retention of avoidance training-participation of dopaminergic mechanisms
Brain Res Clarke 323 390 1984 10.1016/0006-8993(84)90320-2 Autoradiographic distribution of nicotine receptors in rat brain
Psychopharmacology Colrain 108 448 1992 10.1007/BF02247419 Effects of post-learning smoking on memory consolidation
Psychopharmacol Bull Conners 32 67 1996 Nicotine and attention in adult ADHD
Science Coyle 219 1184 1983 10.1126/science.6338589 Alzheimer’s disease
Soc Neurosci Abstr Cregan 15 731 1989 Spatial working memory enhancement by nicotine of aged Long-Evans rats in the T-maze
Biol Psychiatry Decina 28 502 1990 10.1016/0006-3223(90)90483-I Cigarette smoking and neuroleptic-induced Parkinsonism
Life Sci Decker 56 545 1995 10.1016/0024-3205(94)00488-E Diversity of neuronal nicotinic acetylcholine receptors
Eur J Pharmacol Decker 261 217 1994 10.1016/0014-2999(94)90323-9 Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats
Pharmacol Biochem Behav Decker 45 571 1993 10.1016/0091-3057(93)90508-Q Effects of lobeline, a nicotinic receptor agonist, on learning and memory
Behav Neurosci Dunnett 104 655 1990 10.1037/0735-7044.104.5.655 Proactive interference effects on short-term memory in rats
Neuroscience Felix 81 1009 1997 10.1016/S0306-4522(97)00224-8 Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats
Biol Psychiatry Freedman 38 22 1995 10.1016/0006-3223(94)00252-X Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia
J Neurosci Freedman 13 1965 1993 10.1523/JNEUROSCI.13-05-01965.1993 Alpha-Bungarotoxin binding to hippocampal interneurons-immunocytochemical characterization and effects on growth factor expression
Giacobini 367 1988 Nicotinic Acetylcholine Receptors in the Nervous System The cholinergic receptor system in the frontal lobe of Alzheimer’s patients
Nature Gray 383 713 1996 10.1038/383713a0 Hippocampal synaptic transmission enhanced by low concentrations of nicotine
Neurobiol Learn Memory Grigoryan 65 135 1996 10.1006/nlme.1996.0016 6-OHDA lesions of the nucleus accumbens accentuate memory deficits in animals with lesions to the forebrain cholinergic projection system
Pharmacol Biochem Behav Grigoryan 49 511 1994 10.1016/0091-3057(94)90063-9 Are the cognitive-enhancing effects of nicotine in the rat with lesions to the forebrain cholinergic projection system mediated by an interaction with the noradrenergic system?
Neurosci Res Hamid 29 81 1997 10.1016/S0168-0102(97)00074-6 Nicotine induces long-lasting potentiation in the dentate gyrus of nicotine-primed rats
J Subst Abuse Hatsukami 1 407 1989 10.1016/S0899-3289(20)30005-5 The effects of varying cigarette deprivation duration on cognitive and performance tasks
Exp Clin Psychopharmacol Heishman 2 1 1994 Nicotine and smoking
Am J Psychiatry Hughes 143 993 1996 Prevalence of smoking among psychiatric outpatients
Behav Brain Res Jarrard 71 1 1995 10.1016/0166-4328(95)00034-8 What does the hippocampus really do?
Psychopharmacology Jones 108 485 1992 10.1007/BF02247426 Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer’s disease
Kellar 341 1990 Nicotine Psychopharmacology Nicotinic cholinergic receptors in Alzheimer’s disease
Brain Res Kim 725 231 1996 10.1016/0006-8993(96)00213-2 Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens
Schizophr Bull Leonard 22 431 1996 10.1093/schbul/22.3.431 Nicotinic receptor function in schizophrenia
Psychopharmacology Levin 108 418 1992 10.1007/BF02247415 Nicotine systems and cognitive function
Soc Neurosci Abstr Levin 24 183 1998 AR-R 17779, an a7 nicotinic agonist improves learning and memory in rats
Behav Pharmacol Levin 4 179 1993 10.1097/00008877-199304000-00010 Chronic nicotinic stimulation and blockade effects on working memory
Physiol Behav Levin 61 863 1997 10.1016/S0031-9384(96)00609-9 Chronic nicotinic agonist and antagonist effects on T-maze alternation
Drug Dev Res Levin 39 29 1996 10.1002/(SICI)1098-2299(19960901)39:1<29::AID-DDR4>3.0.CO;2-M Chronic nicotine-induced improvement of spatial working memory and D2 dopamine effects in rats
Brain Res Cogn Brain Res Levin 1 137 1993 10.1016/0926-6410(93)90021-V Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection
Brain Res Cogn Brain Res Levin 7 405 1999 10.1016/S0926-6410(98)00044-5 Ventral hippocampal ibotenic acid lesions block chronic nicotine-induced spatial working memory improvement in rats
Psychopharmacology Levin 140 135 1998 10.1007/s002130050750 Transdermal nicotine effects on attention
Psychopharmacology Levin 123 55 1996 10.1007/BF02246281 Nicotine effects on adults with attention-deficit/hyperactivity disorder
Drug Dev Res Levin 46 107 1999 10.1002/(SICI)1098-2299(199902)46:2<107::AID-DDR3>3.0.CO;2-C Bridged nicotine, isonicotine, and norisonicotine effects on working memory performance of rats in the radial-arm maze
Behav Pharmacol Levin 8 236 1997 Acute nicotine interactions with nicotinic and muscarinic antagonists
Psychopharmacology Levin 127 25 1996 10.1007/BF02805971 Chronic nicotine effects on working and reference memory in the 16-arm radial maze
Behav Neural Biol Levin 53 269 1990 10.1016/0163-1047(90)90509-5 Chronic nicotine and withdrawal effects on radial-arm maze performance in rats
Eur J Pharmacol Levin 393 141 2000 10.1016/S0014-2999(99)00885-7 Development of nicotinic drug therapy for cognitive disorders
Behav Pharmacol Levin 1 511 1990 10.1097/00008877-199000160-00005 Anticholinergic sensitivity following chronic nicotine administration as measured by radial-arm maze performance in rats
Pharmacol Biochem Behav Levin 51 369 1995 10.1016/0091-3057(94)00406-9 Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze
Psychopharmacology Levin 138 217 1998 10.1007/s002130050667 Nicotinic acetylcholine involvement in cognitive function in animals
Levin 203 2000 Nicotine in Psychiatry Nicotine effects and attention deficit disorder
Med Chem Res Levin 6 543 1996 Epibatidine, a potent nicotinic agonist
Levin 329 1995 International Symposium on Nicotine Nicotine effects on memory performance
Psychopharmacology Levin 123 88 1996 10.1007/BF02246285 Acute and chronic nicotine effects on working memory in aged rats
Neuropsychopharmacology Levin 15 429 1996 10.1016/S0893-133X(96)00018-8 Nicotine-haloperidol interactions and cognitive performance in schizophrenics
Neurosci Biobehav Rev Martin 5 473 1981 10.1016/0149-7634(81)90017-8 Nicotine binding sites and their localization in the central nervous system
Psychopharmacology Muir 118 82 1995 10.1007/BF02245253 Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron
Drugs Aging Newhouse 11 206 1997 10.2165/00002512-199711030-00005 Nicotinic system involvement in Alzheimer’s and Parkinson’s diseases
Psychopharmacology Newhouse 95 171 1988 10.1007/BF00174504 Intravenous nicotine in Alzheimer’s disease
Behav Brain Res Nordberg 57 215 1993 10.1016/0166-4328(93)90138-G Clinical studies in Alzheimer patients with positron emission tomography
Nordberg 45 1995 Brain Imaging of Nicotine and Tobacco Smoking Imaging of nicotinic receptors in human brain
Neurosci Lett Nordberg 88 317 1988 10.1016/0304-3940(88)90503-4 Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains
Pharmacol Biochem Behav Ohno 45 89 1993 10.1016/0091-3057(93)90091-7 Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats
J Pharmacol Exp Ther Pacheco 274 767 1995 Cholinesterase inhibitors proposed for treating dementia in Alzheimer’s Disease
Neuropsychol Rev Parks 6 61 1996 10.1007/BF01875368 Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer’s disease
J Neurol Neurosurg Psychiatry Perry 50 806 1987 10.1136/jnnp.50.6.806 Nicotinic receptor abnormalities in Alzheimer’s and Parkinson’s diseases
Can J Neurol Sci Quirion 13 503 1986 10.1017/S0317167100037215 Neurotransmitter and receptor deficits in senile dementia of the Alzheimer’s type
Neurology Raskind 54 2261 2000 10.1212/WNL.54.12.2261 Galantamine in AD
Brain Res Ridley 376 108 1986 10.1016/0006-8993(86)90904-2 Learning impairment following lesion of basal nucleus of Meynert in the marmoset
Brain Res Rinne 547 167 1991 10.1016/0006-8993(91)90588-M A postmortem study of brain nicotinic receptors in Parkinson’s and Alzheimer’s disease
J Pharmacol Exp Ther Rochford 277 1267 1996 Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat
Psychopharmacology Rusted 138 362 1998 10.1007/s002130050682 Effortful processing is a requirement for nicotine-induced improvement in memory
Psychopharmacology Rusted 119 405 1995 10.1007/BF02245856 Effects of post-trial administration of nicotine on human memory
10.1007/978-3-0348-7457-1_79 Sahakian BJ, Jones GMM (1991): The effects of nicotine on attention, information processing, and working memory in patients with dementia of the Alzheimer type. In: Adlkofer F, Thruau K, editors. Effects of Nicotine on Biological Systems. Basel, Switzerland: Birkhauser Verlag, 623-230.
Biochemistry Salomon 35 13568 1996 10.1021/bi9617264 Nicotine inhibits amyloid formation by the beta-peptide
Harv Rev Psychiatry Samuels 6 11 1998 10.3109/10673229809010950 Experimental approaches to cognitive disturbance in Alzheimer’s disease
Pharmacol Biochem Behav Sasaki 38 921 1991 10.1016/0091-3057(91)90265-4 Nicotine improves cognitive disturbance in rodents fed with a choline-deficient diet
Schroder 73 1995 Brain Imaging of Nicotine and Tobacco Smoking Nicotinic receptors in Alzheimer’s disease
Life Sci Schwartz 38 2111 1986 10.1016/0024-3205(86)90210-9 Autoradiographic distribution of high affinity muscarinic and nicotinic cholinergic receptors labled with [3H] acetylcholine in rat brain
J Neurochem Shimohama 46 288 1986 10.1111/j.1471-4159.1986.tb12960.x Changes in nicotinic and muscarinic receptors in Alzheimer-type dementia
Dementia Snaedal 7 47 1996 The effcts of nicotine in dermal plaster on cognitive functions in patients with Alzheimer’s disease
Neurobiol Aging Socci 16 857 1995 10.1016/0197-4580(95)00091-R Nicotine enhances Morris water maze performance of young and aged rats
Neuroscience Stancampiano 89 1135 1999 10.1016/S0306-4522(98)00397-2 Serotonin and acetylcholine release response in the rat hippocampus during a spatial memory task
Standaert 503 1996 Goodman & Gilman’s the Pharmacological Basis of Therapeutics Treatment of central nervous system degenerative disorders
J Neurosci Res Sugaya 27 349 1990 10.1002/jnr.490270314 Nicotinic acetylcholine receptor subtypes in human frontal cortex
Neurology Tariot 54 2269 2000 10.1212/WNL.54.12.2269 A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group
Drug Dev Res Terry 40 304 1997 10.1002/(SICI)1098-2299(199704)40:4<304::AID-DDR4>3.0.CO;2-N Cholinergic channel activator, ABT-418, enhances delayed-response accuracy in rats
Psychopharmacology Terry 123 172 1996 10.1007/BF02246174 Effects of stimulation or blockade of central nicotinic-cholinergic receptors on performance of a novel version of the rat stimulus discrimination task
Psychopharmacology Warburton 135 305 1998 10.1007/s002130050514 Evaluation of the information processing and mood effects of a transdermal nicotine patch
Psychopharmacology Warburton 115 539 1994 10.1007/BF02245578 Improvements in performance without nicotine withdrawal
Psychopharmacology White 143 158 1999 10.1007/s002130050931 Four week nicotine skin patch treatment effects on cognitive performance in Alzheimer’s disease
Am J Psychiatry Wilens 156 1931 1999 10.1176/ajp.156.12.1931 A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder
Br J Psychol Williams 71 83 1980 10.1111/j.2044-8295.1980.tb02732.x Effects of cigarette smoking on immediate memory and performance in different kinds of smoker
Pharmacol Biochem Behav Wilson 51 509 1995 10.1016/0091-3057(95)00043-V Nicotine patches in Alzheimer’s disease
Trends Neurosci Wonnacott 20 92 1997 10.1016/S0166-2236(96)10073-4 Presynaptic nicotinic ACh receptors
Prog Brain Res Wonnacott 79 157 1989 10.1016/S0079-6123(08)62475-9 Presynaptic modulation of transmitter release by nicotinic receptors
Eur J Pharmacol Zarrindast 295 1 1996 10.1016/0014-2999(95)00628-1 Effects of nicotine on memory retrieval in mice
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.